-
NUMBER OF INSIDER BUYING
(Last 12 Months)
1 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
7 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$9.91 M -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$21.57 M
Sarepta Therapeutics, Inc. Insider Transactions
Sarepta Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Arif Bilal
Chief Tech Ops Officer |
Sell | 1,543 @ $128.58 | $198,399 | 27,293 | 03/01/2024 | 03/05/2024 | |
|
Arif Bilal
Chief Tech Ops Officer |
Sell | 457 @ $129.71 | $59,277 | 26,836 | 03/01/2024 | 03/05/2024 | |
| Sell | 1,200 @ $128.30 | $153,960 | 39,114 | 03/01/2024 | 03/05/2024 | ||
|
Brown Ryan Edward
EVP, General Counsel |
Sell | 2,000 @ $125.34 | $250,680 | 31,827 | 03/01/2024 | 03/05/2024 | |
|
Barry Richard
Director |
Buy | 40,000 @ $78.81 | $3.15 M | 140,000 | 11/03/2023 | 11/06/2023 | |
|
Barry Richard
Director |
Buy | 10,000 @ $78.81 | $788,100 | 10,000 | 11/03/2023 | 11/06/2023 | |
|
INGRAM DOUGLAS S
CEO |
Buy | 200 @ $81.26 | $16,252 | 390,307 | 11/03/2023 | 11/06/2023 | |
|
INGRAM DOUGLAS S
CEO |
Buy | 3,884 @ $80.33 | $312,002 | 390,107 | 11/03/2023 | 11/06/2023 | |
|
INGRAM DOUGLAS S
CEO |
Buy | 11,060 @ $79.70 | $881,482 | 386,223 | 11/03/2023 | 11/06/2023 | |
|
INGRAM DOUGLAS S
CEO |
Buy | 10,081 @ $78.57 | $792,064 | 375,163 | 11/03/2023 | 11/06/2023 | |
|
Chambers Michael Andrew
Director |
Buy | 4,032 @ $109.89 | $443,076 | 246,996 | 08/14/2023 | 08/15/2023 | |
|
Chambers Michael Andrew
Director |
Buy | 5,947 @ $109.19 | $649,353 | 242,964 | 08/14/2023 | 08/15/2023 | |
|
Chambers Michael Andrew
Director |
Buy | 23,686 @ $108.05 | $2.56 M | 237,017 | 08/11/2023 | 08/14/2023 | |
|
Chambers Michael Andrew
Director |
Buy | 31,570 @ $106.26 | $3.35 M | 213,331 | 08/10/2023 | 08/11/2023 | |
|
Chambers Michael Andrew
Director |
Buy | 1,091 @ $105.90 | $115,537 | 181,761 | 08/10/2023 | 08/11/2023 | |
|
Chambers Michael Andrew
Director |
Buy | 2,206 @ $104.67 | $230,902 | 180,670 | 08/10/2023 | 08/11/2023 | |
|
Wigzell Hans Lennart Rudolf
Director |
Sell | 15,000 @ $106.72 | $1.60 M | 20,994 | 08/04/2023 | 08/08/2023 |
Sarepta Therapeutics, Inc. Frequently Asked Questions
-
Who is on Sarepta Therapeutics, Inc.'s Insider Roster?
The list of insiders at Sarepta Therapeutics, Inc. includes Brown Ryan Edward, Estepan Ian Michael, Arif Bilal, Mayo Stephen, Wigzell Hans Lennart Rudolf, Boor Kathryn Jean, Murray Dallan, Chambers Michael Andrew.
-
How much insider selling is happening at Sarepta Therapeutics, Inc.?
Insiders have sold a total of 141,129 Sarepta Therapeutics, Inc. shares in the last 12 months for a total of 21.57 M sold.
-
Which Sarepta Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold Sarepta Therapeutics, Inc. shares in the last 12 months: Brown Ryan Edward ($12.84 M), Estepan Ian Michael ($1.80 M), Arif Bilal ($4.09 M), Mayo Stephen ($385,480), Wigzell Hans Lennart Rudolf ($1.85 M), Boor Kathryn Jean ($93,550), Murray Dallan ($508,900),
-
How much insider buying is happening at Sarepta Therapeutics, Inc.?
Insiders have purchased a total of 74,076 Sarepta Therapeutics, Inc. shares in the last 12 months for a total of 9.91 M sold.
-
Which Sarepta Therapeutics, Inc. insiders have been buying company stock?
The following insiders have purchased Sarepta Therapeutics, Inc. shares in the last 12 months: Chambers Michael Andrew ($9.91 M),